Canada markets open in 5 hours 12 minutes

DexCom, Inc. (DXCM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
68.55-1.16 (-1.66%)
At close: 04:00PM EDT
68.89 +0.34 (+0.50%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close69.71
Open69.83
Bid68.46 x 300
Ask68.57 x 400
Day's Range68.06 - 70.01
52 Week Range62.34 - 142.00
Volume2,557,550
Avg. Volume5,350,598
Market Cap27.47B
Beta (5Y Monthly)1.18
PE Ratio (TTM)42.58
EPS (TTM)1.61
Earnings DateOct 24, 2024 - Oct 28, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est97.25
  • Business Wire

    Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission

    SAN DIEGO, September 10, 2024--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts in space as part of the Polaris Dawn mission, which launched this morning and aims to better understand the effects of spaceflight on human health.

  • Insider Monkey

    Here’s Why DexCom (DXCM) Fell in Q2

    Investment advisory firm Ithaka Group released the “Ithaka US Growth Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The second quarter of 2024 saw a surge in optimism among global markets, driven by the anticipation of a looser monetary policy from the Federal Reserve and the ongoing development prospects presented by […]

  • Business Wire

    Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium

    EDINBURGH, Scotland, September 04, 2024--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at an upcoming symposium during the European Association for the Study of Diabetes (EASD) Conference on Monday, 9th September, 1300 – 1430 CEST. The symposium will feature expert panellists from endocrinology Prof. Michael Joubert MD PhD, France, primary care, Prof.